ReviewBiomedicines2025

Risk Stratification and Optimal Use of Implantable Cardioverter-Defibrillator Therapy in Primary Prevention of Sudden Cardiac Death in Genetic Cardiomyopathies, with Assessment of the Role of Genetic Variants in Guiding Therapeutic Decisions.

Eleonora Ruscio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.